UBS Group
ICUI icon

UBS Group’s ICU Medical ICUI Stock Holding History

UBS Group’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,400
Closed -$3.26M – 8246
2019
Q3 		$3.26M Buy
+20,400
New +$4.06M ﹤0.01% 2801

Other funds holding ICUI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's ICUI Position: Q1 2026 in Review

UBS Group reduced its ICU Medical (ICUI) stake by 36% in Q1 2026, selling an estimated $9.41M and leaving 114,138 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2921.

UBS Group first reported a position in ICUI in Q4 2014 and has held it in 46 quarters since. The position peaked at $46.4M in Q3 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • UBS Group held 114,138 shares of ICU Medical worth $14.7M as of Q1 2026.
  • UBS Group sold 65,438 ICU Medical shares in Q1 2026, an estimated $9.41M.
  • ICU Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2921 holding.
  • UBS Group first reported a position in ICU Medical in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's ICU Medical position peaked at $46.4M in Q3 2025.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.